HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Surgical treatment of left ventricular aneurysm (author's transl)].

Abstract
174 cardiac aneurysms were resected between 1970 and 1977. In 49 patients the remaining contractile segment was revascularised at the same time. The hospital mortality was 10.3%, the late mortality was 14%. The uncorrected cumulative survival rate calculated by the acturial method was 90% at 3 years (84--96), and 80% at 5 years (74--85). Results were excellent or good in two thirds of the survivors; 44% were free of angina pectoris, 40% were improved, 73% had no disturbances of cardiac rhythm, and in 15% they were improved. Comparison of the pre- and postoperative ejection fraction showed that the indication for surgery of a cardiac aneurysm exists when more than 20% of the musculature of the left ventricle is affected, when the total ejection fraction is larger than 10% when one vessel is affected, and more than 30% when more than one vessel is affected. Contraindications are diffuse coronary heart disease, when ejection fraction of the contractile segment is less than 30% reduction in contractility of the ventricular septum, and the generally applicable surgical contraindications.
AuthorsJ Weniger, J von der Emde, K Bachmann
JournalDeutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr) Vol. 104 Issue 18 Pg. 665-70 (May 04 1979) ISSN: 0012-0472 [Print] Germany
Vernacular TitleChirurgische Behandlung des linksventrikulären Aneurysmas. Prognostische Uberlegungen.
PMID446279 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Heart Aneurysm (diagnosis, mortality, surgery)
  • Heart Septum (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Postoperative Complications
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: